VISTAGEN THERAPEUTICS, INC. Chemicals Revenue (Deprecated 2016-01-31)
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Chemicals Revenue (Deprecated 2016-01-31) of $187.20 thousand for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-14.
Discontinued › Income Statement › Other Income
us-gaap:ChemicalsRevenue · last filed 2012-08-14
- VISTAGEN THERAPEUTICS, INC. chemicals revenue (deprecated 2016-01-31) for the quarter ending 2012-06-30 was $187.20K, a 60.51% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. chemicals revenue (deprecated 2016-01-31) for the quarter ending 2011-06-30 was $474.10K.
| Period end | Chemicals Revenue (Deprecated 2016-01-31) 3 month |
|---|---|
| 2012-06-30 | $187.20K 10-Q · filed 2012-08-14 |
| 2011-06-30 | $474.10K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |